Vaccines Europe pipeline review 2024
Vaccines Europe
|
December 4 2024
Vaccines Europe conducted a pipeline review of its 14 member companies, including information up to August 2024. The review shows a promising vaccines pipeline aimed at tackling the challenges of today and tomorrow, such as the burden of respiratory tract infections, AMR, the ageing of the population, climate change and zoonotic infections, through leveraging a broad array of technology platforms.
